Cell Signalling 1


  • Animal Cell Compartmentalization:

    • The cytoplasmic membrane separates the intracellular environment (cytoplasm and cellular organelles) from the extracellular space.

    • The cytoplasmic membrane is not merely a static barrier; it acts as an active communication platform that:

    • Controls the movement of substances into and out of the cell.

    • Detects extracellular chemical and physical signals.

    • Facilitates direct communication between neighboring cells.

    • Assists in cell-to-cell attachment and tissue integrity.

    • Membrane Permeability:

    • Certain small, nonpolar, or uncharged molecules can freely cross the lipid bilayer without dedicated transport proteins, including:

      • Oxygen (O2\text{O}_2)

      • Carbon dioxide (CO2\text{CO}_2)

      • Nitric oxide (NO2\text{NO}_2)

      • Steroid hormones (lipophilic molecules)

  • Fluid Mosaic Model of Membrane Structure:

    • Conceptually described as "islands of proteins in a sea of lipids."

    • Composed of a fluid lipid bilayer interspersed with integral membrane proteins, transmembrane proteins, glycoproteins, and cholesterol.


Fluid Mosaic Model of Plasma Membrane
  • Phospholipid Architecture:

    • Phospholipids are the foundational structural components of all cellular membranes.

    • Amphipathic Molecular Structure:

    • Polar Head Group: Composed of a hydrophilic head attached via a phosphate group to a glycerol backbone. Common head groups include serine, choline, ethanolamine, or inositol.

    • Hydrophobic Tail: Composed of two fatty acyl side chains linked to the glycerol backbone via ester bonds.


Phospholipid Structure
  • Regulation of Membrane Fluidity by Fatty Acids and Cholesterol:

    • Each phospholipid contains two fatty acid tails that govern overall membrane fluid dynamics based on saturation level and hydrocarbon chain length:

    • Fully Saturated Fatty Acids: Contain zero double bonds (C=CC=C). Examples include:

      • Myristic acid (14:014:0)

      • Palmitic acid (16:016:0)

      • Stearic acid (18:018:0)

    • Mono-unsaturated Fatty Acids: Contain a single double bond (C=CC=C). Example:

      • Oleic acid (18:118:1)

    • Poly-unsaturated Fatty Acids: Contain multiple double bonds (C=CC=C). Example:

      • Arachidonic acid (20:420:4)

    • Degree of Saturation Effects: Cis-double bonds in unsaturated fatty acids create physical "kinks" in the hydrocarbon tails. These kinks disrupt close packing, leading to less stable van der Waals interactions among neighboring lipids, which increases membrane fluidity.

    • Chain Length Effects: Short-chain fatty acids reduce the overall contact area and interaction potential of the hydrocarbon chains, thereby increasing fluidity.

    • Cholesterol and Lipid Rafts:

    • High cholesterol content restricts the random motion of polar head groups, stabilizing the membrane and decreasing fluidity.

    • Cholesterol concentrates in specialized microdomains known as lipid rafts, which serve as concentrated platforms for receptor complexes and signalling molecules.


Fatty Acids and Membrane Fluidity

Principles of Chemical Signalling

  • Cellular Responses Driven by Signalling:

    • Cell signalling governs essential cell functions and behaviors, directing cells to:

    • Grow

    • Divide (proliferation)

    • Differentiate into specialized cell types

    • Secrete and release bio-molecules

    • Mobilize or store energy reserves

    • Die (programmed cell death / apoptosis)

    • Differential Interpretation: The exact same extracellular chemical signal can be interpreted differently depending on the specific receptor complement and intracellular machinery of different recipient cell types.

    • Consequences of Absent Signalling: Without effective cell signalling, critical physiological processes cannot take place, including:

    • Wound healing

    • Tissue repair

    • Immune responses

    • Tooth development

  • The Six Key Steps of Extracellular Signalling:

    1. Synthesis and release of the chemical signalling molecule by the signalling cell.

    2. Transport of the signal across space or fluids to the specific target cell.

    3. Detection of the incoming signal by a specific binding protein (receptor) at the target cell (located either on the plasma membrane or intracellularly).

    4. Transmission of the signal to the cytoplasmic side to effector molecules down an intracellular signalling pathway.

    5. Cellular Response: The final triggered biological effect, such as the activation of specific gene transcription.

    6. Termination: Removal of the signal, resulting in the shut-off or attenuation of the cellular response.

Classification of Extracellular Signalling Molecules

  • Hormones and Growth Factors (Sexual and Developmental):

    • Oestradiol

    • Progesterone

    • Growth Hormone

    • Nerve Growth Factor (NGF)

    • Epidermal Growth Factor (EGF)

  • Metabolic Regulators:

    • Insulin

    • Adrenaline (Epinephrine)

    • Glucagon

    • Cortisol

  • Neurotransmitters:

    • Glutamate

    • Acetylcholine (ACh)

    • Dopamine

    • GABA (γ\gamma-aminobutyric acid)

    • Opioids

  • Inflammatory Mediators:

    • Prostaglandins

    • Thromboxanes

    • Cytokines

Modes of Chemical Signalling

  • Classification Based on Acting Distance:


Autocrine Paracrine Endocrine Signaling
  • Autocrine Signalling:

    • The signalling molecule is released by a cell and binds to receptors on the same cell (or identical neighboring cells) to regulate its own function.

    • Example 1 (Inflammatory Macrophages): Macrophages activated during an inflammatory response secrete the cytokine Interleukin-1 (IL-1\text{IL-1}). These same macrophages express Interleukin-1 Receptors (IL-1R\text{IL-1R}). Binding of IL-1\text{IL-1} triggers an intracellular cascade driving further secretion of IL-1\text{IL-1}, establishing a positive forward feedback loop that keeps the macrophage in an activated inflammatory state.

    • Example 2 (Oncology): The self-sustaining, uncontrolled proliferation of cancer cells is frequently driven by autocrine secretion of growth factors.


Autocrine Macrophage Activation
  • Paracrine Signalling:

    • The signalling molecule is released by a secretory cell and diffuses locally through the extracellular fluid to act on adjacent target cells in close proximity (typically within a range of a few micrometers, μm\mu m).

    • Example (Transmission at the Neuromuscular Junction):

      1. An action potential arrives at the pre-synaptic cholinergic axon terminal.

      2. Synaptic vesicles fuse with the terminal membrane and release Acetylcholine (ACh\text{ACh}) into the synaptic cleft.

      3. ACh\text{ACh} diffuses across the cleft and binds to ligand-gated ion channel receptors on the motor end plate of the muscle cell membrane.

      4. Ligand binding opens the channel pores, permitting the influx of sodium ions (Na+\text{Na}^+) into the muscle fiber.

      5. Local depolarization occurs, producing an end-plate potential.

    • Other Paracrine Functions: Essential in local pain sensation, salivary secretion mechanisms, and localized wound healing processes.


Neuromuscular Junction Transmission
  • Endocrine Signalling:

    • Endocrine glands synthesize and secrete signalling molecules called hormones directly into the vascular bloodstream.

    • The bloodstream transports the hormones throughout the organism to reach distant target cells (distances up to several meters away).

    • Example (Parathyroid Hormone - PTH): Produced by parathyroid glands, PTH\text{PTH} travels through the blood to target receptors in:

      • Bones: Increases osteoclast activity, promoting bone resorption and calcium release into blood.

      • Kidneys: Promotes renal tubular calcium reabsorption and catalyzes the activation of vitamin D into active calcitriol.


Anatomy of Thyroid and Parathyroid Glands

Stages of Signal Conversion and Receptor Classification

  • Three Universal Stages of Cellular Signalling:

    1. Reception: Extracellular primary messenger (signal molecule) binds specifically to a receptor.

    2. Transduction: Binding alters receptor structure, initiating an intracellular signal-transduction pathway involving relay proteins and secondary messengers.

    3. Response: Activation of specific effector proteins produces a physiological cell response, such as altered metabolic pathways or modified gene transcription in the nucleus.


Three Stages of Signal Transduction
  • Principles of Signal Reception:

    • Cell-Surface Receptors: Because most primary messengers are water-soluble and membrane-impermeable, they must bind to high-affinity integral membrane proteins on the cell surface.

    • Intracellular Receptors: Lipophilic (fat-soluble) molecules, such as steroid hormones, pass through the lipid bilayer and bind to cytosolic or nuclear receptors.

    • Pharmacological Modulation:

    • Agonist: A ligand that binds to a receptor and induces a conformational change that activates the receptor to initiate a biological response.

      • Clinical Example: Pilocarpine is a muscarinic acetylcholine receptor agonist used to stimulate salivary gland secretion in patients suffering from xerostomia (dry mouth).

    • Antagonist: A ligand that binds to a receptor with high affinity without activating it, preventing normal agonist access and activation.

      • Clinical Example: Atropine is a muscarinic receptor antagonist that blocks receptor binding, leading to reduced salivary secretions.

  • The Three Major Classes of Cell Surface Receptors:

    • Ionotropic Receptors (Ligand-Gated Ion Channels):

    • Membrane channels that open or close directly upon ligand binding.

    • Examples: Nicotinic acetylcholine receptor, Ionotropic glutamate receptor.

    • Metabotropic Receptors (7-Transmembrane G-Protein Coupled Receptors - GPCRs):

    • Receptors containing seven membrane-spanning domains coupled to intracellular heterotrimeric G-proteins.

    • Examples: β\beta-adrenergic receptor, Glucagon receptor.

    • Catalytic Receptors (Enzyme-Linked / Tyrosine Kinase Receptors):

    • Receptors possessing intrinsic enzymatic activity or directly linked to intracellular protein kinases upon ligand-induced dimerization.

    • Examples: Insulin receptor, Nerve Growth Factor (NGF) receptor.

Intracellular Signalling, Effector Enzymes, and Second Messengers

  • Signal Relay and Organizing Components:

    • Scaffold Proteins: Large proteins containing multiple binding domains that physically organize distinct components of a signalling cascade into structural complexes, maximizing efficiency and spatial-temporal specificity.

    • Adaptor Proteins: Smaller linker proteins that connect two specific protein partners within a cascade.

  • Second Messengers:

    • Small, non-protein molecules or ions that rapidly diffuse within the cytoplasm to amplify and relay external primary signals throughout the cell interior.

    • Properties and Classification:

    • Hydrophilic Molecules: Cyclic AMP (cAMP\text{cAMP}), Inositol 1,4,5-trisphosphate (IP3\text{IP}_3) — diffuse through cytosol.

    • Hydrophobic Molecules: 1,2-Diacylglycerol (DAG\text{DAG}) — remains within the plane of the lipid bilayer.

    • Amphipathic Molecules: Arachidonic acid.

    • Ions: Calcium (Ca2+\text{Ca}^{2+}).

    • Gases: Nitric Oxide (NO\text{NO}), Cyclic GMP (cGMP\text{cGMP}).

  • Effector Enzymes and Second Messenger Generation:

    • Specific activated receptors couple to effector enzymes, which synthesize or release second messengers:

    • Adenylyl Cyclase: Effector enzyme that converts ATP\text{ATP} into Cyclic AMP (cAMP\text{cAMP}).

    • Phospholipase C (PLC): Effector enzyme that cleaves membrane phosphatidylinositol 4,5-bisphosphate (PIP2\text{PIP}_2) into:

      • Inositol 1,4,5-trisphosphate (IP3\text{IP}_3): Diffuses to the endoplasmic reticulum to trigger Ca2+\text{Ca}^{2+} release.

      • 1,2-Diacylglycerol (DAG\text{DAG}): Membrane-bound activator of Protein Kinase C (PKC).

G-Protein Coupled Receptor (GPCR) Mechanisms and Signalling Pathways

  • Structural Architecture of GPCRs:

    • Constructed from a single polypeptide chain folded into seven transmembrane α\alpha-helical domains (labelled I through VII).

    • Contains an extracellular N-terminal chain, three extracellular loops, three intracellular loops (including a highly variable intracellular loop regulating G-protein specificity), and a C-terminal chain located in the cytoplasm.


GPCR Structural Diagram
  • Conformational Activation Example (β\beta-Adrenergic Receptor):

    • Endogenous Agonists: Epinephrine (Adrenaline), Norepinephrine (Noradrenaline).

    • Exogenous Synthetic Agonists: Salbutamol, a β2\beta_2-adrenergic agonist used clinically to relieve bronchospasm in conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).

    • Agonist binding induces a spatial shift in the 7-transmembrane helices, exposing internal binding interfaces for heterotrimeric G-proteins.

  • Heterotrimeric G-Protein Cycle:

    • Structure: Molecular switches consisting of three distinct subunits: α\alpha, β\beta, and γ\gamma

    • Inactive State: In the absence of a signal, the α\alpha subunit holds Guanosine Diphosphate (GDP\text{GDP}) and remains tightly bound to the βγ\beta\gamma complex (αβγ−GDP\alpha\beta\gamma-\text{GDP}).

    • Activation Steps:

    1. Agonist binds to GPCR, causing a conformational change.

    2. Activated GPCR binds to the heterotrimeric G-protein complex.

    3. GDP\text{GDP} dissociates from the α\alpha subunit and is rapidly replaced by Guanosine Triphosphate (GTP\text{GTP}).

    4. GTP\text{GTP} binding triggers structural dissociation of the active Gα−GTP\text{G}\alpha-\text{GTP} subunit from both the receptor and the βγ\beta\gamma dimer.

    5. Free Gα−GTP\text{G}\alpha-\text{GTP} diffuses along the membrane to bind and regulate specific effector enzymes.

    • Self-Termination (GTPase Activity): The Gα\text{G}\alpha subunit possesses intrinsic GTPase enzyme activity that hydrolyzes bound GTP\text{GTP} back to GDP\text{GDP} (GTP→GDP+Pi\text{GTP} \rightarrow \text{GDP} + P_i). Upon hydrolysis, Gα−GDP\text{G}\alpha-\text{GDP} reassociates with the βγ\beta\gamma dimer to restore the inactive trimeric complex.

  • The Adenylyl Cyclase / cAMP Signalling Pathway (Gs\text{G}_s Stimulation):

    • Mechanism:

    • Agonist binds β\beta-adrenergic receptor →\rightarrow activates Gαs\text{G}\alpha_s

    • Gαs−GTP\text{G}\alpha_s-\text{GTP} activates membrane-bound Adenylyl Cyclase.

    • Adenylyl Cyclase catalyzes ATP→cAMP\text{ATP} \rightarrow \text{cAMP}, elevating intracellular cAMP\text{cAMP} concentration.


Adenylyl Cyclase Activation by Gs
  • Protein Kinase A (PKA) Activation:

    • Inactive PKA\text{PKA} exists as a tetrameric complex of two Regulatory (R\text{R}) subunits and two Catalytic (C\text{C}) subunits (\text{R}_2\n\text{C}_2).

    • cAMP\text{cAMP} binds specifically to the regulatory subunits, causing them to dissociate and liberate active catalytic (C\text{C}) subunits.

    • Active C\text{C} subunits phosphorylate specific serine and threonine residues on target proteins (ATP→ADP+Pi\text{ATP} \rightarrow \text{ADP} + P_i).

  • Downstream Targets:

    • Short-Term Effects: Rapid enzymatic and metabolic changes.

    • Long-Term Effects: PKA\text{PKA} translocates to the nucleus and phosphorylates CREB (cAMP Response Element-Binding Protein), a transcription factor that activates target gene transcription.

  • Signal Termination: cAMP\text{cAMP} is enzymatic degraded into inactive 5′-AMP5'\text{-AMP} by the enzyme Phosphodiesterase.


cAMP and PKA Signaling Pathway
  • Physiological Application: β\beta-Adrenergic "Fight or Flight" Metabolic Cascade:

    • Stimulation by adrenaline/noradrenaline raises cAMP\text{cAMP} and activates PKA\text{PKA}, triggering two concurrent metabolic cascades:

    1. Glycogen Degradation: PKA\text{PKA} phosphorylates and stimulates Glycogen Phosphorylase Kinase, which phosphorylates and activates Glycogen Phosphorylase, resulting in increased glycogen breakdown.

    2. Inhibition of Glycogen Synthesis: PKAPKA phosphorylates and inactivates Glycogen Synthase, resulting in decreased glycogen production.

    • Tissue-Specific Outcomes:

    • Liver: Releases free glucose into the blood stream to fuel distant tissues.

    • Skeletal Muscle: Retains glucose within muscle cells to produce ATP\text{ATP} required for rapid contraction.

  • Inhibition of Adenylyl Cyclase (Gi\text{G}_i Pathway):

    • Receptors coupled to Gi\text{G}_i proteins (e.g., CB1 Cannabinoid Receptor) recruit Gαi\text{G}\alpha_i upon ligand binding.

    • Active Gαi−GTP\text{G}\alpha_i-\text{GTP} directly binds and inhibits Adenylyl Cyclase, decreasing intracellular cAMP\text{cAMP} synthesis.


Inhibition of Adenylyl Cyclase by Gi
  • Phospholipase C / Ca2+\text{Ca}^{2+} Pathway (Gq/11\text{G}_{q/11} Pathway):

    • Receptors coupled to Gq/11\text{G}_{q/11} (e.g., M1-muscarinic receptor binding ACh\text{ACh}, or α1\alpha_1-adrenergic receptor) recruit Gαq\text{G}\alpha_q

    • Gαq−GTP\text{G}\alpha_q-\text{GTP} activates Phospholipase C (PLC).

    • PLCPLC hydrolyzes membrane PIP2PIP_2 into IP3IP_3 and DAGDAG:

    • IP3IP_3 binds to ligand-gated Ca2+Ca^{2+} channels on the endoplasmic reticulum, releasing intracellular Ca2+Ca^{2+} into the cytosol.

    • Elevated cytosolic Ca2+Ca^{2+} stimulates key cellular actions, such as saliva secretion in salivary glands.

    • DAGDAG along with Ca2+Ca^{2+} activates Protein Kinase C (PKC), which phosphorylates cellular target proteins to yield further biological responses.


Phospholipase C Activation Pathway
  • Summary Comparison of G-Protein Pathways:

Receptor (Ligand Example)

G-Protein Class

Primary Effector Enzyme

Second Messenger Response

β\beta-Adrenergic (Adrenaline)

Gs\text{G}_s (Stimulatory)

Adenylyl Cyclase

Increases cAMP\text{cAMP}

CB1 Cannabinoid

Gi\text{G}_i (Inhibitory)

Adenylyl Cyclase

Decreases cAMP\text{cAMP}

M1-Muscarinic (Acetylcholine) / α1\alpha_1-Adrenergic

Gq/11\text{G}_{q/11}

Phospholipase C (PLC)

IP3\text{IP}_3 (releases Ca2+\text{Ca}^{2+} from stores) & DAG\text{DAG} (activates PKC)

Significance of Cell Signalling and G-Proteins in Dentistry

  • Oral Tissue Development and Maintenance:

    • Governs embryonic tooth development, salivary gland morphogenesis, and continuous bone remodeling in alveolar bone.

    • Plays essential roles in periodontal ligament (PDL) and gingival fibroblast dynamics.

  • Inflammation and Immune Responses:

    • Mediates inflammatory cell recruitment and cytokine cascades in oral pathologies such as pulpitis, periodontitis, and periodontal disease.

  • Pain Perception and Analgesia:

    • Regulates nociceptive signal transmission in dental pulp and surrounding oral tissues.

    • Understanding receptor-ligand interaction pathways is essential for the rational design and administration of local anesthetics and analgesics.

  • Oncology and Pathology:

    • Somatic mutations in G-proteins and associated GPCR signalling pathways are strongly implicated in oral tumor growth, oncogenesis, and metastatic potential.

  • Salivary and Sensory Function:

    • Controls fluid and electrolyte secretion from salivary glands via muscarinic and adrenergic GPCR pathways, and regulates taste receptor cell signalling.

Practice Questions and Clinical Scenarios

  • Question 1: A hormone binds to a cell-surface receptor and activates an intracellular signalling pathway. Which of the following is an example of a second messenger?

    • Insulin

    • Epidermal Growth Factor (EGF)

    • Acetylcholine

    • cAMP

    • Adrenaline

    • Answer Explanation: cAMP is a second messenger synthesized intracellularly by adenylyl cyclase. Insulin, EGF, acetylcholine, and adrenaline are primary messengers (ligands).

  • Question 2: A cell signalling molecule has the following functions:

    • It binds to a cell-surface receptor

    • It activates an effector enzyme

    • It acts as a molecular switch

    • It helps generate secondary messengers

    • Which molecule is being described?

    • Ligand

    • Receptor

    • G protein

    • cAMP

    • Calcium ion

    • Answer Explanation: Heterotrimeric G-proteins act as molecular switches (active with GTP, inactive with GDP) that couple cell-surface receptors to effector enzymes to generate second messengers.

  • Question 3: A patient has a tooth extracted. Growth factors released in the socket stimulate nearby epithelial and connective tissue cells to divide and migrate into the wound. What type of signalling is occurring?

    • Endocrine

    • Autocrine

    • Paracrine

    • Intracellular

    • Synaptic

    • Answer Explanation: Local release of signalling molecules affecting nearby cells in close physical proximity without entering the bloodstream represents classic paracrine signalling.